Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 453-468

  Lucassen, Paul J ^a,b,c   Müller, Marianne B ^e   Holsboer, Florian ^e   Bauer, Jan ^f   Holtrop, Anne ^b   Wouda, Jose ^b   Hoogendijk, Witte J G ^b,d   De Kloet, E Ron ^a   Swaab, Dick F ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; AMINOGLUTETHIMIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; BUTYROPHENONE; CAPTOPRIL; CISAPRIDE; DEXAMETHASONE; DIGOXIN; ENALAPRIL MALEATE; FLUCLOXACILLIN; GLUCOCORTICOID; HALOPERIDOL; HEAT SHOCK PROTEIN 70; HYDROXYUREA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MORPHINE; OPIATE; PACLITAXEL; PARACETAMOL; PREDNISONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEPRESSION; DRUG MEGADOSE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MENTAL DISEASE; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0035135843     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63988-0     Document Type: Article

References (143)

1. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin
2. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
3. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
4. Brain corticosteroid receptor balance in health disease
5. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamopituitary-adrenocortical axis
6. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis
7. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
8. Atrophy of hippocampal formation subdivisions correlates with stage duration of Alzheimer disease
9. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
10. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging
11. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
12. Cortisol secretion and Alzheimer's disease progression
13. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment
14. Hippocampal aging and adrenocorticoids: Quantitative correlations
15. Brain aging correlates: Retardation by hormonal-pharmacological treatments
16. Repeated stress causes reversible impairments of spatial memory performance
17. The acute effects of corticosteroids on cognition: Integration of animal and human model studies
18. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats
19. Steroid hormones and excitability in the mammalian brain
20. Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging
21. A mechanism for glucocorticoid toxicity in the hippocampus: Increased neuronal vulnerability to metabolic insults
22. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus
23. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus
24. Hippocampal damage associated with prolonged glucocorticoid exposure in primates
25. Hippocampal damage associated with prolonged fatal stress in primates
26. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
27. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression
28. Adrenal gland enlargement in major depression. A computed tomographic study
29. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings new directions
30. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
31. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders
32. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls
33. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment
34. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression
35. Why stress is bad for your brain
36. Hippocampal atrophy in recurrent major depression
37. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
38. Corticosterone impairs hippocampal neuronal calcium regulation - Possible mediating mechanisms
39. The role of calcium in the regulation of apoptosis
40. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity
41. Glucocorticoids may alter antioxidant enzyme capacity in the brain: Kainic acid studies
42. Glucocorticoids increase the accumulation of reactive oxygen species enhance adriamycin-induced toxicity in neuronal culture
43. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus
44. Microwave-enhanced in situ end-labeling of fragmented DNA: Parametric studies in relation to postmortem delay and fixation of rat human brain
45. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
46. Expression of c-fos and hsp70 mRNA in neonatal rat cerebrocortical slices during NMDA-induced necrosis and apoptosis
47. The neuroprotective potential of heat shock protein 70 (HSP70)
48. Inhibition of NFκB DNA binding activity by glucocorticoids in rat brain
49. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease
50. Inhibition of NF-κB potentiates amytoid beta-mediated neuronal apoptosis
51. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells
52. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA
53. DNA damage distribution in the human brain as shown by in situ end labeling: Area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology
54. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks
55. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
56. Mutational analysis of the human HSP70 protein: Distinct domains for nucleolar localization and adenosine triphosphate binding
57. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis
58. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease
59. Apoptosis
60. Apoptosis: An overview
61. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor κB
62. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
63. The neurobiology of depression
64. A. E. Bennett Research Award. Regulation of serotonin 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression
65. Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: A re-evaluation study
66. Hippocampal volume reduction in major depression
67. Hippocampal abnormalities in depression
68. Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging
69. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter
70. The human hippocampus in major depression or following administration of glucocorticoids: No evidence for major structural alterations
71. Stress and hippocampal plasticity
72. Stress and the aging hippocampus
73. Glucocorticoid hypersecretion and the age-impaired hippocampus: Cause or effect?
74. Glucocorticoids, stress, and their adverse neurological effects: Relevance to aging
75. Stress-induced declarative memory impairment in healthy elderly subjects: Relationship to cortisol reactivity
76. Stress and cognitive function
77. Decreased memory performance in healthy humans induced by stress-level cortisol treatment
78. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews
79. Glucocorticoids accelerate ATP loss following metabotic insults in cultured hippocampal neurons
80. Glucocorticoid toxicity in the hippocampus reversal by supplementation with brain fuels
81. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion
82. Glucocorticoids may alter antioxidant enzyme capacity in the brain: Baseline studies
83. Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: Implications for the pathogenesis of Alzheimer's disease
84. The in vivo time course for elimination of adrenalectomy-induced apoptotic profiles from the granule cell layer of the rat hippocampus
85. A suicide note from Alzheimer disease neurons?
86. Apoptosis Alzheimer's disease
87. Presenilins and DNA damage; a link through amyloid?
88. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
89. Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes
90. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
91. TUNEL apoptotic cell detection in tissue sections: Critical evaluation improvement
92. Microwave-enhanced in situ end labeling; pitfalls and limitations
93. Cortisol levels during human aging predict hippocampal atrophy and memory deficits
94. Increased cortisol levels and impaired cognition in human aging: Implication for depression and dementia in later life
95. Corticosteroids, the aging brain and cognition
96. Structural and functional abnormalities in elderly patients clinically recovered from early-late-onset depression
97. Hippocampal volume losses in minimally impaired elderly
98. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease
99. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress
100. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: Relationship with spatial learning in young aged rats
101. Antidepressants restore hypothalamic-pituitary-adrenal feedback function in aged, cognitively-impaired rats
102. Regulation of corticosteroid receptor gene expression in depression and antidepressant action
103. Cushing's syndrome after treatment: Changes in cortisol and ACTH levels, and amelioration of the depressive syndrome
104. Comments on review by Coleman and Flood, 'Neuron Numbers and Dendritic Extent in Normal Aging and Alzheimer's Disease.' Density measures: Parameters to avoid
105. Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias
106. Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study
107. Ligand and subfield specificity of corticoid-induced neuronal loss in the rat hippocampal formation
108. Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates
109. Chronic psychosocial stress does not affect the number of pyramidal neurons in tree shrew hippocampus
110. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young mid-aged rats
111. Remodeling of hippocampal synapses after hippocampus-dependent associative learning
112. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits
113. Morphometric studies of the aged hippocampus: I. Volumetric analysis in behaviorally characterized rats
114. Memory impaired aged rats: No loss of principal hippocampal subicular neurons
115. Modulation of glucocorticoid receptor gene expression by antidepressant drugs
116. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function
117. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus
118. Glucocorticoid receptors in depression
119. Distribution of corticosteroid receptors in the rhesus brain: Relative absence of glucocorticoid receptors in the hippocampal formation
120. Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats
121. Increased glucocorticoid receptor gene expression in the rat hippocampus following combined serotonergic and medial septal cholinergic lesions
122. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo
123. Differential induction of NF-kappa B activity and neural cell death by antidepressants in vitro
124. Glial responses to steroids as markers of brain aging
125. Apoptotic cell death in neurons and glial cells: Implications for Alzheimer's disease
126. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy
127. Stress genes protect brain
128. Transcription factor NF-κB: Friend or foe of neurons?
129. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro
130. Transcription factor NF-κB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease
131. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice
132. Why dexamethasone poorly penetrates in brain
133. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone
134. Adrenalectomy-induced granule cell degeneration in the rat hippocampal dentate gyrus: Characterization of an in vivo model of controlled neuronal death
135. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons
136. Chronic psychosocial stress differentially affects apoptosis in hippocampal subareas and cortex of the adult tree shrew
137. Cranial computed tomography (CCT) findings in children treated with ACTH and dexamethasone: First results
138. Verbal memory impairment resulting from hippocampal neuron loss among epileptic patients with structural lesions
139. The effects of long-term corticosterone administration on hippocampal morphology ann cognitive performance of middle-aged rats
140. Hippocampal volume in primary unipolar major depression a magnetic resonance imaging study
141. Quantitative MRI of the hippocampus and amygdala in severe depression